Company Lpath, Inc. Nasdaq
Equities
US5489103060
Medical Equipment, Supplies & Distribution
End-of-day quote
Other stock markets
|
||
- USD | - |
2023 | Apollo Endosurgery, Inc.(NasdaqGM:APEN) dropped from S&P TMI Index | CI |
2023 | Apollo Endosurgery, Inc.(NasdaqGM:APEN) dropped from S&P Global BMI Index | CI |
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Founder | 73 | 31/12/04 | |
Thomas Neudeck
CTO | Chief Tech/Sci/R&D Officer | - | - |
Chief Tech/Sci/R&D Officer | - | - | |
Brian Szymczak
CMP | Compliance Officer | 51 | 30/09/14 |
Vance Brown
BRD | Director/Board Member | 54 | - |
Keely Scamperle
PRN | Corporate Officer/Principal | - | 16/01/22 |
Kirk Ellis
SAM | Sales & Marketing | - | 09/05/21 |
Sales & Marketing | - | 09/05/21 | |
Mike Gutteridge
SAM | Sales & Marketing | - | 29/02/16 |
Comptroller/Controller/Auditor | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Vance Brown
BRD | Director/Board Member | 54 | - |
Jonathan Monson
BRD | Director/Board Member | 50 | 03/04/23 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 57,971,919 | 38,371,462 ( 66.19 %) | 0 | 66.19 % |
Company contact information
Apollo Endosurgery, Inc.
1120 South Capital of Texas Highway Suite 300
78746, Austin
+
http://apolloendo.comSector
1st Jan change | Capi. | |
---|---|---|
+72.98% | 12.38B | |
-20.40% | 7.76B | |
+6.24% | 6.61B | |
+12.78% | 5.4B | |
+38.73% | 4.96B | |
-18.08% | 4.75B | |
-24.72% | 3.89B | |
-29.57% | 2.66B | |
+52.38% | 2.45B |
- Stock Market
- Equities
- APEN Stock
- Stock
- Company Lpath, Inc.